Spliceosome mutations are common in persons with myeloproliferative neoplasm-associated myelofibrosis with RBC-transfusion-dependence and correlate with response to pomalidomide

Eitemau Tebyg

• Spliceosome mutations are common in MPN-associated myelofibrosis with RBC-transfusion-dependence and correlate with response to pomalidomide
  gan: Chowdhury, O, et al.
  Cyhoeddwyd: (2018)
• Non-driver mutations in myeloproliferative neoplasm-associated myelofibrosis
  gan: Bing Li, et al.
  Cyhoeddwyd: (2017-05-01)
• Mechanisms of disease transformation in myeloproliferative neoplasms
  gan: O'Sullivan, J
  Cyhoeddwyd: (2022)
• Heterogeneity in myeloproliferative neoplasms: causes and consequences
  gan: O'Sullivan, J, et al.
  Cyhoeddwyd: (2018)
• Profile of pomalidomide and its potential in the treatment of myelofibrosis
  gan: Gowin KL, et al.
  Cyhoeddwyd: (2015-04-01)